From Illumina to Nanopore to PacBio, getting high-quality sequencing data starts long before the run begins. Careful library prep, accurate quantification, platform-specific QC checks, and novel RNA ...

Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2026 results , with sales up 4.8% year on year to $1.09 billion. The ...

With the strong start to the year, Illumina bumped up its guidance. It now expects revenue between $4.52 billion and $4.62 billion, up $20 million at the midpoint versus its prior guidance. It now ...

Patient Capital Management, a value investing firm, released its “Patient Opportunity Equity Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, ...

Increased adoption of clinical whole-genome sequencing is advancing diagnostics for rare diseases, which affect 15 million American children SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Illumina, Inc.

In 2021, a technology developed at University of Michigan, called Seq-Scope, revolutionized the ability to map gene activity within intact tissue at microscopic resolution, enabling researchers to ...

Together, these advances increase daily sequencing productivity and expand the range of applications that can be run at scale on a single instrument. With higher output, increased accuracy, faster run ...

40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts are among the updates to be rolled out on all NovaSeq X systems, advancing ...

Element Biosciences is going toe-to-toe with gene-sequencing giant Illumina, unveiling a device that can read DNA for half the price of the industry leader’s technology. On Thursday, Element ...

The Southern white rhino Edward samples a birthday box of hay in 2020. Southern white rhinos are connected to the effort to revive the critically endangered northern white rhino, which has deposits in ...